Patent US1409520A successfully refreshed from Google Patents.
Patent US5055296A successfully refreshed from Google Patents.
US5055296A
Expired / Lapsed
US
⏱️ 0.0 years remaining
Method of treating chronic fatigue syndrome
Assignee: Kremers Urban Co
•
Filing: 1988-08-04
•
Granted: 1991-10-08
•
Expires: 2008-08-04
Abstract
Abstract A therapeutic method for treating viral infections and chronic fatigue syndrome. The method comprises administering a therapeutically-effective amount of a mammalian liver extract, the extract being characterized by being heat stable, insoluble in acetone and soluble in water.
Inventors
- 👤 Sudhakar S. Wagle
- 👤 S. Ken Tanaka
- 👤 Thomas Steinbach
- 👤 Carl H. Lawyer
- 👤 William J. Hermann, Jr.
Bibliographic Details
Application Number
—
Jurisdiction
US
Data Source
google_patents
Last Synchronized
2026-10-23 09:57
CPC Classifications
B; B01; B01L; B01L3/00; B01L3/02; B01L3/0289; B01L3/0293; A; A61; A61K; A61K35/00; A61K35/12; A61K35/37; A61K35/407; G; G01; G01N; G01N1/00; G01N1/02; G01N1/10; G01N1/18; B65; B65B; B65B3/00; B65B3/003; Y; Y10; Y10S; Y10S530/00; Y10S530/827; Y10S530/843; Y10S530/846
Claims Analysis
Total Claims: 5
Claim 1
Independent Claim
48 words
A method of treating chronic fatigue syndrome which comprises administering to a person suffering from this syndrome a therapeutically-effective amount of a mammalian liver extract which is referred to herein as KU 10,001, the extract being characterized by being heat stable, insoluble in acetone and soluble in water.
Claim 2
Independent Claim
48 words
A method of treating chronic fatigue syndrome which comprises administering to a person suffering from this syndrome a therapeutically-effective amount of a mammalian liver extract which is referred to herein as KU 10,001, the extract being characterized by being heat stable, insoluble in acetone and soluble in water.
Claim 3
Dependent Claim
24 words
The method of claim 1 wherein the liver extract is contained in a pharmaceutically-acceptable carrier at a concentration of about 2.5% by weight solids.
Claim 4
Dependent Claim
24 words
The method of claim 2 wherein the liver extract is contained in a pharmaceutically-acceptable carrier at a concentration of about 2.5% by weight solids.
Claim 5
Dependent Claim
13 words
The method of claim 3 wherein the liver extract is contained in water.
References Cited (Backward Citations)
US3778510A
Cited
US3788510A
Cited
US4148788A
Cited
US4603122A
Cited
US4426324A
Cited
US4602037A
Cited
US4622430A
Cited
US4464355A
Cited
US4603219A
Cited
US4428938A
Cited
US4614651A
Cited
US4420398A
Cited
US4537878A
Cited
US4598095A
Cited
US4596798A
Cited
US4629811A
Cited
US4468379A
Cited
US4609661A
Cited
US4609662A
Cited
US4612314A
Cited
US4625026A
Cited
US4668660A
Cited
US4631149A
Cited
US4708818A
Cited
US4614731A
Cited
US4605658A
Cited
US4595780A
Cited
US4621140A
Cited
US4628063A
Cited
US4617304A
Cited
US4595588A
Cited
US4626524A
Cited
US4606917A
Cited
US4644055A
Cited
US4604404A
Cited
US4605659A
Cited
US4670437A
Cited
US4699898A
Cited
US4710380A
Cited
USPTO Annuity & Maintenance Windows
| Annuity Stage | Window Opens | Payment Deadline | Surcharge Period Until | Estimated Fee | Status |
|---|---|---|---|---|---|
| 3.5 Years (Year 4) | 1994-10-07 | 1995-04-08 | 1995-10-08 | $2000.00 | Window Closed / Lapsed |
| 7.5 Years (Year 8) | 1998-10-07 | 1999-04-08 | 1999-10-08 | $3760.00 | Window Closed / Lapsed |
| 11.5 Years (Year 12) | 2002-10-07 | 2003-04-08 | 2003-10-08 | $7700.00 | Window Closed / Lapsed |